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Sickle cell anaemia (SCA) is associated with zinc deﬁciency; zinc supplementation may ameliorate some of its clinical
manifestations including the relief of painful crisis. Subjects and Methods. Serum zinc levels were determined in 71 children with
SCA and painful crisis and in equal numbers in steady state. Seventy-one children with AA genotype acted as controls. Qualitative
assessment of zinc content of 24-hour dietary recall and the last meal consumed before blood was drawn was taken. Serum zinc
was determined using atomic absorption spectrophotometer. Haemoglobin concentration and packed cell volume (PCV) were
determinedusingstandardmethods.Results.Themeanserumzincconcentrationinthestudywaslessthaninternationalreference
range. The controls had signiﬁcantly higher serum zinc concentrations than the SCA group (42.7 ± 13.6v e r s u s3 2 .3 ± 14.0μg/dL,
P<. 000); this diﬀerence was due to the signiﬁcantly lower values of serum zinc in SCA with painful crisis compared with the
remaining two groups F = 30.9, P<. 000. There was a positive correlation between serum zinc and haemoglobin concentration
only in the control group (r = 0.4; P = .001). Conclusion. The serum zinc levels in this study were low. Painful crisis in SCA may
exert greater demand for zinc utilization in children with SCA thereby resulting in lower serum levels.
1.Introduction
Sickle cell anaemia is the most common inherited disorder
of the black race. It aﬀects red blood cells resulting in
chronic haemolytic anaemia of varying severity and in some
patients, periodic painful crisis caused by the occlusion of
small blood vessels by spontaneous intravascular sickling
with multiorgan aﬀectation [1, 2].
Brewer and Oelshlegel discovered that calcium binding
to red cell membrane is responsible for the formation
of irreversible sickled cells and that the antisickling eﬀect
of zinc in sickle cell anaemia is due to its ability to
antagonize calcium binding to red cell membrane [3].
In sickle cell anaemia, there is also increased oxidative
stress and peroxidation as well as low antioxidant poten-
tial which predisposes the patients to vaso-occlusive crisis
[4–6]. Zinc exerts its antioxidant action by inhibition of lipid
peroxidationwhichoccursinredbloodcellsandliverthereby
stabilizing biomembranes and biostructures thus protecting
the body against oxidative stress [5, 6]. These eﬀects of zinc
are believed to give zinc its ability to reduce vaso-occlusive
crisis in sickle cell anaemia.
Various studies have shown that zinc deﬁciency may
be common in SCA patients. This has been attributed to
chronic haemolysis that occurs in these patients, increased
demand and utilization, along with the secondary loss of
zinc in the urine [1, 7, 8]. Furthermore, supplementation
of zinc in sickle cell anaemia has been reported to improve
wound healing, decrease incidence of infection, improve
the age of attaining secondary sexual characteristics, reverse
dark adaptation of the eyes, and accelerate growth [8–
12].2 Anemia
Although it has been suggested that zinc therapy could
reduce painful crisis [13, 14]; however, it has not been shown
with certainty that zinc deﬁciency in sickle cell anaemia
is directly related to the development or severity of vaso-
occlusive crisis. Prasad et al. [15], in 1976 administered
oral zinc sulfate to 10 adults who had severe painful crisis
and found symptomatic improvement in 8 of the subjects,
which they attributed to the antisickling eﬀect of zinc. The
signiﬁcance of their ﬁndings may be limited because of the
very small sample size and lack of control subjects in the
study. In a placebo-controlled double-blind study, 145 sickle
cell adult subjects were treated with either 220mg of zinc
sulphate 3 times daily or placebo [14]. After 18 months, the
zinc-treated subjects had an average of 2.5 crises, compared
to 5.3 in the placebo group; but the severity of painful crisis
was not reduced. A study in Ibadan, Nigeria [16]f o u n d
no relationship between serum zinc level and the diﬀerent
degrees of clinical severity of the disease in these subjects.
They observed that the level of zinc in each patient, though
signiﬁcantly lower than the controls, had no correlation
with the haematocrit, frequency of bone pain crisis, and
susceptibility to infection. The sample size in their study was
also small making it diﬃcult to draw any valid inference.
It is probable that zinc deﬁciency may be associated with
painful crisis. However, these authors are not aware of any
previous work comparing zinc status in sickle cell anaemic
patients in vaso-occlusive crisis with those in steady state.
This study is therefore designed to assess the level of serum
zinc in sickle cell anaemia children in painful state (vaso-
occlusive crisis) as compared with those in steady state. We
alsorelatethelevelsofserumzincwithdietandhaemoglobin
levels in the subjects.
2.SubjectsandMethods
This was a case-controlled study of patients at the Lagos
University Teaching Hospital (LUTH), Nigeria. The sample
size for the study and the number of subjects for each arm
were determined using standard formulae for population
study [17], using the prevalence rate of SCA in western
Nigeria [18] and the rate of deﬁcient erythrocyte zinc level in
sickle cell anaemia children in Zaria [19]. One hundred and
forty-two paediatric subjects aged between one and 12 yrs
whohadhaemoglobingenotypeSSwerestudied.Ofthese,71
were in had bone pain crisis and were recruited consecutively
from both the haematology clinic and Children’s Emergency
Room (CHER) the remainder were in steady state recruited
from the sickle cell clinic. The control group consisted of 71
apparently well subjects whose haemoglobin genotype was
AA. They were recruited from the Well Baby and Children’s
Outpatient Clinic. Both the SCA in steady state subjects and
the controls were selected such that they were matched for
age and sex with the subjects who had painful crisis.
In this study, sickle cell anaemia in painful crisis was
deﬁned as subjects who had pains at the time of recruitment
or within 48 hours before recruitment in any of the
limbs [20], while steady state was deﬁned as subjects who
were apparently well without evidence of recent infection,
bone pain, or other problems for at least 4 weeks before
recruitment [21]. The study, which was approved by the
research and ethics committee of the hospital, lasted for a
period of 12 months. Other inclusion criteria were that study
population were not on any zinc-containing medications,
they were fed at least 4 hours before blood collection, and
had not been transfused with blood or blood products in the
previous three months preceding study. Also included were
subjectswhodidnothaveanysymptomsorsignsofinfection
such as fever (axillary temp <37.0◦C), acute respiratory
infection, diarrhoea, or malaria. Additionally, controls had
no evidence of chronic disease including protein energy
malnutrition. The haemoglobin genotype of all the subjects
was determined by haemoglobin cellulose electrophoresis.
After informed consent, a detailed history of each child
from the care-giver was taken; these included the mother’s
and father’s educational status and occupation, 24-hour
meal recall, date of last blood transfusion, and the presence
or absence of pain in the limbs. Physical examination
including assessment for the presence or absence of fever
(temp >37.0◦C), jaundice, pallor, ﬁnger clubbing, liver
size, spleen size, and tenderness in the limbs, the weight,
and length/height was done. Previous health status of each
subject was obtained by examining the hospital records. Five
mLofbloodwascollectedfromeachsubjectbyvenepuncture
afterappropriateskinpreparationswitha21-gaugestainless-
steel needle with a polypropylene syringe (Norm-Ject; Henke
Sass Wolf GMBH, Germany) [22]. Two mL of blood
was transferred into a sodium ethylenediamine-tetra-acetate
(EDTA) bottle for haemoglobin (Hb), Packed cell volume
(PCV), and haemoglobin genotype determination using
standard laboratory procedure. The remaining 3mL was
transferred into zinc free nonheparinized bottles previously
washed clean of possible zinc contamination by leaving them
soaked in 10% nitric acid for 24 hours and rinsed three times
with deionised water. The clotted blood sample in the zinc-
free bottles was centrifuged at 1500rpm for 10 minutes and
the serum removed with zinc free Pasteur Pipette prepared
by previously washing with 10% nitric acid and thoroughly
rinsedwithdeionisedwaterasdescribedforthebottlesabove
[23]. The serum samples were then stored at −20◦C pending
analysis [24]. All haemolysed samples were discarded. Before
the analysis, the serum samples were allowed to come to
room temperature and each mixed by gently inverting the
tube four times. Serum zinc level was determined using an
atomic absorption spectrophotometer (PU9100X, Philips,
Holland) at the Food Technology laboratory of the Federal
Institute of Industrial Research Oshodi (FIIRO) Lagos,
Nigeria and following the method of Smith et al. [22].
The concentration of each sample, which was expressed
in parts per million, was extrapolated from the calibration
curve prepared from the standard zinc calibration curve and
converted to μg/dL by calculation.
3. Classiﬁcationof ZincContent in
24-Hour MealRecall
The zinc contents of 24-hour meal recall and the last meal
consumed before blood was taken were classiﬁed based onAnemia 3
Table 1: Mean haematological parameters and serum zinc concentration in Cases and Controls.
Parameter
Genotype (Mean ± 2SD)
FP -value
Genotype AA (n = 71) Sickle cell anaemia
Steady state n = 71 Painful crisis n = 71
Age (mo) 71.3 ±34.36 7 .2 ± 30.17 9 .9 ± 31.7 2.9 .06
Weight (Kg) 21.1 ±8.01 7 .9 ± 5.42 0 .3 ± 6.3 4.6 .01
Height (cm) 115.7 ±21.1 108.4 ± 16.8 115.7 ± 17.8 3.6 .03
Hb (g/dL) 11.3 ±2.07 .1 ± 1.17 .6 ± 1.6 144.9 .00
PCV (%) 33.1 ±5.62 0 .9 ± 3.42 2 .3 ± 4.8 143.9 .00
Serum Zinc Conc (μg/dL) 42.7 ±13.63 8 .4 ± 13.82 6 .3 ± 11.3 30.9 .00
P<. 05 is signiﬁcant.
the concentration of zinc in food items consumed by the
subject. Thus each food item was classiﬁed as containing
high, moderate, or low zinc [25, 26]. Meals which contain
items such as plantain, red beef, sea foods, egg, milk, cocoa
products, and ﬁsh were classiﬁed as high zinc content, while
beans, cereals made out of maize and rice products contain
moderate zinc. Cassava products were classiﬁed as having
traces or low zinc content [25, 26]. For the purpose of this
study, a subject who had more than 2 high zinc containing
items with any 3 moderate zinc containing items or all high
zinc containing items was classiﬁed as having high zinc diet.
A subject who had one high zinc containing item and less
than 3 moderate zinc containing items or had all moderate
zinc containing items was classiﬁed as having moderate zinc,
while a subject who had one moderate zinc or one high zinc
containing item with low zinc containing item, or only low
zinc containing items, was classiﬁed as having low zinc.
4.DataAnalysis
Data generated was analysed using the SPSS statistical
package version 11. Frequency distributions were generated
for all categorical variables. The measures of location were
determined for quantitative outcome such as age, zinc level,
and haematocrit. Statistical signiﬁcance between two means
was assessed using Student t-test, while one-way analysis of
variance was used where there were multiple means. Where
there was signiﬁcant diﬀerence within means, post hoc test
was applied to determine where the level of signiﬁcance
occurred. Chi-square (χ2) test was applied for categorical
variables and correlation analysis as applicable. Diﬀerences
betweenvalueswereacceptedasstatisticallysigniﬁcantwhere
probability was less than.05.
5. Results
Two hundred and thirteen children aged between one and 12
yrs were recruited into the study; seventy-one were controls
with haemoglobin genotype AA, while one hundred and
forty-two subjects had haemoglobin genotype SS. Seventy
one of the subjects with sickle cell anaemia were in steady
state while the rest had vaso-occlusive bone pain crisis.
Eighty-two of the study subjects were males and 60 were
females giving a male:female ratio of 1.3:1. This diﬀerence
was not statistically signiﬁcant. Also, the male: female ratio
for each of the subgroup was not signiﬁcantly diﬀerent.
The mean ages of the subjects in control group and those
with sickle cell anaemia were 71.3 ± 34.3 months and 73.6 ±
31.4 months, respectively. The diﬀerence was not statistically
signiﬁcant. (t = 0.5, P = .64). Although the control subjects
were heavier than the SCA subjects (weight (kg), 21.1 ± 8.0
versus 19.1 ± 6.0, t = 2.1, P = .04) and they were also
taller, (height (cm) 115.7 ± 21.1 versus 112.1 ± 17.6, t =
1.3, P = .2), the diﬀerences were not statistically signiﬁcant.
However,thecontrolsubjectshadameanpackedcellvolume
of 33.1 ± 5.6% and haemoglobin of 11.3 ± 2.0g/dLwhich
were signiﬁcantly higher (t = 16.9, P = .000) than the SCA
group with a mean packed cell volume of 21.6 ± 4.2% and
haemoglobin concentration of 7.4 ± 1.4g/dL, respectively.
The mean serum zinc concentration in the control subjects
was also signiﬁcantly higher than the sickle cell anaemia
group(42.7±13.6v ersus32.3±14.0μg/dL,t = 5.2,P = .000)
When the sickle cell anaemia group was subdivided into
those in steady state and those with bone pain crisis, the
mean age remained not signiﬁcantly diﬀerent although the
mean age for subjects with painful crisis was higher than
those of sickle cell anaemia in steady state and the control
subjects. Sickle cell anaemia subjects in steady state were
however signiﬁcantly shorter than those with painful crisis
and with haemoglobin AA. Similarly, sickle cell anaemia
subjects in steady state were signiﬁcantly lighter than the
controls (P = .01) subjects and sickle cell anaemia subjects
with painful crisis. The signiﬁcant diﬀerence observed in
the haemoglobin concentration and packed cell volume
was found to be between the control group and the sickle
cell anaemia in painful crisis and sickle cell anaemia in
steady state. Although the sickle cell anaemia in painful
crisis had higher haematological parameters than the steady
state subjects, the diﬀerence was not statistically signiﬁ-
cant. The mean serum zinc concentration in subjects with
haemoglobin genotype SS in steady state of 38.4±13.8μg/dL
wassigniﬁcantlyhigherthaninsubjectswithbonepaincrisis
of 26.3 ± 11.3μg/dL (P<. 001). The result also showed
signiﬁcantly higher mean serum zinc concentration levels
(P<. 001) in controls when compared with subjects in bone
pain crisis. However, the diﬀerences between control and
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Figure 1: Mean zinc concentration by age groups in the three
subgroups.
The subjects were arranged into four age groups. Thirty
three subjects (15.5%) were between 13 and 35 months of
age, 57 (26.7%) were in the age group of 36–71 months,
the majority (83, 39.0%) were between 72 and 107 months
of age and the remaining 40 (18.8%) were between 108–
144 months of age. There were, however, no signiﬁcant
diﬀerences in the numbers of subjects in the diﬀerent age
groups (P>. 03). The mean serum levels of zinc for the age
groups for all the subjects ranged from 36.21±12.8μg/dL for
age group of 13–35 months, 39.5 ± 15.6μg/dL for age group
of 36–71months, 35.6±16.0μg/dL, to 30.7±10.2μg/dL, for
age groups of 108–144 months. The diﬀerences in the values
were statistically signiﬁcant F = 2.9, P = .04.
When the subjects were grouped into controls, sickle
cell steady state, and painful crisis, however, the control
subjects had higher mean serum zinc levels than the sickle
cell anaemia subgroups in all age groups except in the age
group of 108–144 months where the steady state subjects
had higher levels than the control group. These diﬀerences
were statistically signiﬁcant and the level of signiﬁcance was
between the controls and the sickle cell anaemia subjects in
painful crisis except in the age group of 108–144 months
where the level of signiﬁcance was between the sickle cell
anaemia in steady state and SCA in painful crisis. Among the
controls, there was a signiﬁcant fall in serum zinc levels as
the subjects get older, F = 5.0, P = .004, but such decrease
in zinc levels with age was not observed among the sickle cell
subgroups; F = 0.8, P = .3 (in sickle cell anaemia in steady
state and F = 0.5, P = .7 in sickle cell anaemia subjects
in painful crisis). In all the age groups, the SCA in painful
crisis had serum zinc levels signiﬁcantly lower than those of
controls and subject with SCA in steady state (Figure 1).
Figure 2showsthecorrelationbetweenhaemoglobinand
serum zinc concentrations. There is a positive correlation
between haemoglobin concentration and zinc levels in the
control group and this was signiﬁcant (r = 0.4, P<
.001). There was no correlation observed in the steady states
subjects (r = 0.01, P = .4 )a n di ns u b j e c t si nb o n ep a i n
crisis (r = 0.01, P = .9).
Haemoglobin concentration (g/dL)
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Figure 2: Linear relationship between haemoglobin concentration
to serum zinc levels in Control, SCA in steady state, and SCA in
painful crisis.
The eﬀect of dietary intake of zinc-containing meals on
serum zinc was assessed. Ten (4.7%) subjects were assessed
to have consumed meals low in zinc content in the last 24
hours, 6 of these were SCA in steady state and 3 were SCA
in painful crisis; the remaining subject in this category was
the control. Ninety seven (45.5%) subjects, consisting of 18
controls, 31 SCA in steady state, and 48 SCA in painful crisis
had food items with moderate zinc content. The remaining
106 (49.8%) subjects of whom 52 were in control group, 34
SCA in steady state, and 20 SCA with painful crisis had food
items containing high level of zinc.
When the zinc content of food items consumed by
subjects 24 hour prior to collection of blood for analysis
were compared with mean serum zinc concentration, it was
found that subjects in the control group whose meal were
adjudged to contain moderate amount of zinc had mean
serum zinc concentration of 41.1 ± 17.2μg/dl compared to
43.3 ± 12.5μg/dl in those whose food items contained high
amount of zinc. This diﬀerence was however not statistically
signiﬁcant. In the SCA group, subjects in the steady state
who consumed low zinc items in their meal had serum zinc
concentration of 30.7 ± 12.1μg/dL, those that consumed
moderate zinc levels had 40.8 ± 14.0 while those thatAnemia 5
Table 2: Relationship between zinc content of 24-hour dietary recall and mean serum zinc level.
Zinc content of meal Mean serum zinc concentration μg/dL (± SD)
FP -value Genotype AA Sickle cell anaemia
Steady state Painful crisis
Low 45.0†† 30.7 (12.1) 33.9 (20.7) t = 0.3. 8
Moderate 41.1 (17.2) 40.8 (14.0) 24.8 (10.5) 18.4 .000
High 43.3 (12.5) 37.6 (13.7) 28.5 (11.4) 9.9 .000
††Only one subject in the control group had low zinc item and was removed from the statistical analysis; therefore, student t-test was used to compare the
mean zinc level between sickle cell anaemia subjects in steady state and painful crisis in the ﬁrst row.
Table 3: Relationship between zinc content of last meal consumed before taking blood and mean serum zinc level.
Zinc content of meal
Mean serum zinc concentration μg/dL (± SD)
FP -value
Genotype AA n = 71 Sickle cell anaemia
Steady state n = 71 Painful crisis n = 71
Low 46.7 (37.8) 29.3 (10.8) 20.0 (9.9) 1.9 .192
Moderate 40.6 (12.5) 37.6 (13.0) 25.7 (10.9) 23.1 .000
High 46.9 (10.8) 55.4 (11.5) 34.4 (11.5) 6.6 .004
consumed high zinc levels had a mean value of 37.6 ± 13.7.
This diﬀerence was not statistically signiﬁcant. SCA subjects
with painful crisis who consumed low zinc containing
meals had mean serum concentration of 33.9 ± 20.7μg/dL.
For those who consumed moderate zinc containing items
had mean serum zinc level of 24.8 ± 10.5μg/dL, and for
those that took high zinc containing items their mean
serum zinc concentration was 28.5 ± 11.4μg/dL. Again this
diﬀerence was not statistically signiﬁcant. However, across
the subgroups, control subjects had mean serum levels of
zinc that were signiﬁcantly higher than those in the SCA
subgroups among subjects that consumed moderate to high
zinc containing meals, Table 2.
When the zinc contents of the last meals consumed
before blood was taken were considered, most subjects, 164
(77.0%) of whom 47, 59, and 58 were in the control, SCA
steady state, and SCA painful crisis subgroups, respectively,
consumed meals containing moderate zinc contents. Thirty-
ﬁve (16.4%) subjects had food items containing high zinc
content; 21 of these subjects were in control group while 6
and 8 subjects were in SCA in steady state and painful crisis,
respectively. The remaining 14 (6.6%) (3 in control group,
6 SCA in steady state, and 5 in SCA painful crisis) had food
items containing low zinc contents.
Using the content of the last meal consumed it was found
that, except in the control groups, those that consumed high
zinc containing meals had highest mean serum zinc levels.
This was signiﬁcant among the SCA in steady state, F = 7.0,
P = .002, and just reached signiﬁcant level in SCA in painful
crisis,F = 3.1,P = .05.Withinthesubgroups,thosewithlow
zinc consumption had no signiﬁcant diﬀerence, the mean
serum zinc level was however signiﬁcantly lower in SCA in
painful crisis than those in controls and steady state who
took food items with moderate zinc content. Similar trend
was observed in those who consumed food items containing
high zinc contents; again the mean serum level for SCA in
painful crisis was signiﬁcantly lower than those of controls
and SCA in steady state, Table 3.
6. Discussion
The serum zinc levels in this group of Nigerian children were
found to be lower than the internationally acceptable normal
values of 50–150μg/dL {7.65–22.95μmol/L} [27]. This is
also true for the control group as well as those with sickle
cell anaemia. Several studies have indicated that nutritional
zinc deﬁciency is widespread all over the world. Akinkugbe
and Ette [28] observed that low zinc levels are common
in Nigerian children. Important risk factors related to zinc
deﬁciencyare common use of grain proteins and low content
of zinc in breast milk of mothers and weaning food [27, 28].
T h e s ef a c t o r sm a yb ei m p o r t a n ti no u rs u b j e c t sa sm o r et h a n
80% were on food containing low or moderate amount of
zinc in their last meal before blood was drawn for analysis.
This should reﬂect more accurately the nature of meal the
child is taking than the 24-hour recall. Most of these food
items contained high level of cassava- and grain-based diet
which limits the quantity of zinc available for absorption due
to their high phosphate and phytate content as zinc forms an
unavailable complex with these compounds [27–29].
Although the subjects had low serum zinc levels, symp-
toms attributable solely to zinc deﬁciency were not found,
especially in the control subjects. It is diﬃcult to say at
what level of serum zinc that symptoms of deﬁciency
would appear, and the reasons for lack of symptoms in the
control subjects is unclear. The signiﬁcantly lower values
of zinc observed in children older than 107 months in the
control group probably reﬂect increased demand for zinc
in already suboptimal zinc nutriture in these subjects at the
commencement of pubertal growth [30].
In all age groups, the serum zinc levels were signiﬁcantly
lower in the SCA group than in the controls. This ﬁnding6 Anemia
has been reported in several communications [6, 7, 15, 30]
and has been attributed to several factors including the
chronic haemolysis that characterizes sickle cell anaemia
leading to loss of zinc from red blood cells which is an
important storage site for zinc [6, 28]. Furthermore, there is
a defective zinc homeostasis as a result of excessive excretion
of zinc in urine or abnormal renal tubular reabsorption of
zinc due to the sickling phenomena, increased demand and
consumption due to increased oxidative stress and sickle
cell redox imbalance [6, 8, 10]. The further lowering of
serum zinc in SCA subjects with painful crisis in this study
was an interesting ﬁnding. It could be postulated that SCA
subjects who are more severely zinc-deﬁcient would have
more painful crisis. On the other hand, frequent painful
crisis might interfere with nutrition and lead to more severe
nutritional deﬁciencies [6].
Zinc is the most abundant intracellular element with
85% of total body zinc found in muscle and bone; less
than 0.1% of total body zinc is in the plasma [31]. Plasma
zinc is maintained by continuous shift from the intracellular
sources and absorption from the intestine. Hence plasma
zinc is a poor indicator of total body zinc. The retention
time of zinc in the blood is estimated as 2.3 days [32];
however, metabolic stress, such as infection and acute
illnesses which are more common in children with sickle cell
disease compared to children with haemoglobin genotype
AA, increases intracellular shift of zinc into the liver and
lowers plasma level even when total body zinc level is
unchanged [33]. As already noted above, the low plasma
zinc level in this study in sickle cell anemia subjects with
painful crisis may indicate the eﬀects of stress in increasing
theintracellularshiftingofzincintotheliverfromtheplasma
of these subjects rather than increased loss of zinc from the
body.
This study showed a positive correlation between the
serum zinc and haemoglobin in the control group. This is
in conformity with the ﬁndings of Akinkugbe and Ette [28],
whose study was on serum zinc and haemoglobin levels in
children with common paediatric problems. However, there
was no correlation between serum zinc and haemoglobin in
the subjects with SCA; this is in conformity with the ﬁnding
of Akenami et al. [16] in sickle cell anaemia children. The
r e a s o nf o rt h i si sn o tc l e a r .I tm a yb ed u et ot h ec h r o n i c
haemolytic state experienced by sickle cell anaemia subjects,
leading to loss of zinc at it is storage site (red blood cell) and
it is urinary loss. Further studies are required to explain this
ﬁnding.
Zinc deﬁciency is associated with poor growth, among
otherclinicalmanifestations[8,34].Inthisstudy,thecontrol
group had signiﬁcantly higher weight and height than the
sickle cell anaemia group in steady state but not with the
SCA group with painful crisis. This may be attributed to the
growth retardation associated with zinc deﬁciency. However,
one would have expected the SCA children with painful
crisis who also had the lowest levels of serum zinc to be
the most aﬀected in growth, but this was not the case. The
Haemoglobin concentration in the SCA with painful crisis
wasalsohigherthanthosewithoutpainfulcrisis.Itispossible
that the higher oxygen-carrying capacity of children with
painful crisis had a better eﬀect on growth than the level of
plasma zinc. Since there was also no signiﬁcant diﬀerence in
the quality of the meals consumed in terms of zinc content
between these groups, it is possible that the lower serum zinc
concentration in SCA subjects with painful crisis resulted
from more severe disease with higher oxidative stress leading
to higher utilization of zinc rather than a poorer serum zinc
status.
Since this study was a cross-sectional one, it was impor-
tant to observe whether the zinc status of these subjects
improved several days after recovery from their painful
episodes or whether zinc therapy would have aborted or
shorten periods of painful episodes. These should form the
basis for our next study in these children.
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